{"database": "lobbying", "table": "lobbying_activities", "rows": [[3009952, "d8e5c3bf-e563-4abf-bfeb-687140005f38", "Q2", "COUNCIL FOR RESPONSIBLE NUTRITION", 11036, "COUNCIL FOR RESPONSIBLE NUTRITION", 2023, "second_quarter", "CSP", "Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to nutritional access for undeserved populations. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. General issues related to the dietary supplements industry.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 120000, 0, 0, "2023-07-18T12:23:12-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3009952"], "units": {}, "query_ms": 1.0358910076320171, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}